Tag: IVL
AVS completes US$36 million Series B financing ahead of IVL US commercial launch
Amplitude Vascular Systems (AVS) recently announced that it has completed a Series B round of financ...
FastWave issued seventh utility patent for its IVL portfolio
FastWave Medical has announced the issuance of its seventh utility patent by the US Patent and T...
Boston Scientific to acquire IVL developer Bolt Medical
Boston Scientific has announced it has entered into a definitive agreement to acquire Bolt Medic...
FastWave Medical closes $19 million financing round to advance IVL portfolio
FastWave Medical has announced the close of a US$19 million funding round earlier this year, inc...
Shockwave Javelin peripheral IVL catheter meets prespecified efficacy and safety performance goals in feasibility and IDE studies
Shockwave Medical, part of Johnson & Johnson MedTech, has announced the first clinical outco...
First patient enrolled in study of integrated laser atherectomy and IVL catheter
Royal Philips has announced enrolment of the first patient in the US THOR IDE clinical trial, which ...
TCT 2024: Six-month data reflect safety and efficacy of Lithix HC-IVL system
Six-month data from the PINNACLE I study evaluating the safety and performance of the LithiX Her...
EMPOWER CAD all-female IVL trial completes enrolment
Shockwave Medical has announced the completion of enrolment in EMPOWER CAD, the first prospective al...
AVS and Jacobs Institute partner on study of Pulse IVL system
Amplitude Vascular Systems (AVS), developer of the Pulse intravascular lithotripsy (IVL) platform an...
Johnson & Johnson completes acquisition of Shockwave Medical
Johnson & Johnson today announced it has completed its acquisition of Shockwave Medical. Shockwa...
FastWave Medical announces successful 30-day first-in-human data on peripheral IVL technology
FastWave Medical has announced the 30-day results of its first-in-human (FIH) study using the co...
FastWave Medical secures multi-million dollar private financing within weeks
FastWave Medical recently announced the swift closure of an oversubscribed multi-million dolla...
AVS’s pulsatile IVL technology attracts an additional US$8.8 million to close US$28.8 million Series B round
AVS, an early-stage medical device company focused on safely and effectively treating severely c...
Shockwave Medical and Genesis MedTech obtain regulatory approval in China for intravascular lithotripsy
Shockwave Medical and Genesis MedTech Group announced today that they have successfully obtained app...
Cardiovascular Systems announces development of IVL technology for the treatment of coronary and peripheral arterial diseases
Cardiovascular Systems recently announced that it has made significant progress towards the commerci...
Shockwave completes enrolment in study of coronary intravascular lithotripsy
Shockwave Medical has completed enrolment in its US Food and Drug Administration (FDA) Investiga...
